Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study

References

• Adrish, M., et al., 2017. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction. International journal of chronic obstructive pulmonary disease, 12, 1183–1189.
   PubMed Web of Science ®Google Scholar
• Ala-Kopsala, M., et al., 2004. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clinical chemistry, 50, 1576–1588.
   PubMed Web of Science ®Google Scholar
• Andersen, M.J., et al., 2014. Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction. Journal of cardiac failure, 20, 959–967.
   PubMed Web of Science ®Google Scholar
• Balion, C.M., et al., 2008. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clinical biochemistry, 41, 231–239.
   PubMed Web of Science ®Google Scholar
• Bartus, K., et al., 2017. Atrial natriuretic peptide and brain natriuretic peptide changes after epicardial percutaneous left atrial appendage suture ligation using LARIAT device. Journal of physiology and pharmacology: an official journal of the Polish physiological society, 68, 117–123.
   PubMed Web of Science ®Google Scholar
• Bernasconi, M., et al., 2011. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD. Chest, 140, 91–99.
   PubMed Web of Science ®Google Scholar
• Boyer, B., et al., 2012. Biomarker changes during acute heart failure treatment. Congestive heart failure (Greenwich, Conn), 18, 91–97.
   PubMedGoogle Scholar
• Brandt, R.R. Jr., et al., 1993. Atrial natriuretic peptide in heart failure. Journal of the American college of cardiology, 22, 86a–92a.
   PubMed Web of Science ®Google Scholar
• Buckley, M.G., Marcus, N.J., and Yacoub, M.H., 1999. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clinical science (London, England: 1979), 97, 689–695.
   PubMed Web of Science ®Google Scholar
• Burnett, J.C. Jr., et al., 1986. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (New York, NY), 231, 1145–1147.
   Google Scholar
• Burrell, L.M. and Baylis, P.H., 1990. Release of atrial natriuretic peptide during hypertonic saline infusion: the importance of posture. Clinical endocrinology (Oxf), 32, 491–496.
   PubMed Web of Science ®Google Scholar
• Burrows, B., et al., 1972. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. The New England Journal of Medicine, 286, 912–918.
   PubMed Web of Science ®Google Scholar
• Calverley, P.M., et al., 2010. Cardiovascular events in patients with COPD: TORCH study results. Thorax, 65, 719–725.
   PubMed Web of Science ®Google Scholar
• Chapeau, C., et al., 1985. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. Journal of histochemistry & cytochemistry, 33, 541–550.
   PubMed Web of Science ®Google Scholar
• Chenevier-Gobeaux, C., et al., 2005. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP). Clinica chimica acta; international journal of clinical chemistry, 361, 167–175.
   PubMed Web of Science ®Google Scholar
• Chenevier-Gobeaux, C., et al., 2010. Midregional Pro–Atrial Natriuretic Peptide for the Diagnosis of Cardiac-Related Dyspnea according to Renal Function in the Emergency Department: a Comparison with B-Type Natriuretic Peptide (BNP) and N-Terminal ProBNP. Clinical chemistry, 56, 1708–1717.
   PubMed Web of Science ®Google Scholar
• Cockcroft, D.W. and Gault, M.H., 1976. Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31–41.
   PubMed Web of Science ®Google Scholar
• Cohen, J.F., et al., 2016. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. British medical journal open, 6, e012799.
   PubMed Web of Science ®Google Scholar
• de Miguel, D.J., Morgan, J.C., and García, R.J., 2013. The association between COPD and heart failure risk: a review. International journal of chronic obstructive pulmonary disease, 8, 305–312.
   PubMed Web of Science ®Google Scholar
• Dietz, J.R., 2005. Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovascular research, 68, 8–17.
   PubMed Web of Science ®Google Scholar
• Douglas, P.S., 2003. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. Journal of the American college of cardiology, 42, 1206–1207.
   PubMed Web of Science ®Google Scholar
• Eckstein, J., et al., 2012. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Heart, 98, 1518–1522.
   PubMed Web of Science ®Google Scholar
• Falk, J.A., et al., 2008. Cardiac disease in chronic obstructive pulmonary disease. Proceedings of the American thoracic society, 5, 543–548.
   PubMedGoogle Scholar
• Garcia, R., Cantin, M., and Thibault, G., 1987. Role of right and left atria in natriuresis and atrial natriuretic factor release during blood volume changes in the conscious rat. Circulation research, 61, 99–106.
   PubMed Web of Science ®Google Scholar
• Gegenhuber, A., et al., 2006. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clinical chemistry, 52, 827–831.
   PubMed Web of Science ®Google Scholar
• Guha, K. and McDonagh, T., 2013. Heart failure epidemiology: European perspective. Current cardiology reviews, 9, 123–127.
   PubMedGoogle Scholar
• Hagdrup, C., et al., 2017. Mr-Proanp rises during exercise even after surgical closure of the left atrial appendage: a sub-study of the Laacs randomized study. Journal of cardiology and vascular medicine, 3, 1–7. doi: 10.17303/jcvm.2017.3.102
   Google Scholar
• Heining, L., Giesa, C., and Ewig, S., 2016. MR-proANP, MR-proADM, and PCT in patients presenting with acute dyspnea in a medical emergency unit. Lung, 194, 185–191.
   PubMed Web of Science ®Google Scholar
• Høiseth, A.D., et al., 2012. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort study. Respiratory research, 13, 97
   PubMed Web of Science ®Google Scholar
• Hulks, G. and Thomson, N.C., 1994. High dose inhaled atrial natriuretic peptide is a bronchodilator in asthmatic subjects. The European respiratory journal, 7, 1593–1597.
   PubMed Web of Science ®Google Scholar
• Hunt, P.J., et al., 1995. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochemistry biophysiology research communications, 214, 1175–1183.
   PubMed Web of Science ®Google Scholar
• Hunt, P.J., et al., 1997. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clinical endocrinology (Oxf), 47, 287–296.
   PubMed Web of Science ®Google Scholar
• Januzzi, J.L. Jr., et al., 2005. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American journal of cardiology, 95, 948–954.
   PubMed Web of Science ®Google Scholar
• Kimura, K., et al., 2007. ANP is cleared much faster than BNP in patients with congestive heart failure. European journal of clinical pharmacology, 63, 699–702.
   PubMed Web of Science ®Google Scholar
• Kohno, M., et al., 1992. Pulmonary arterial brain natriuretic peptide concentration and cardiopulmonary hemodynamics during exercise in patients with essential hypertension. Metabolism: clinical and experimental, 41, 1273–1275.
   PubMed Web of Science ®Google Scholar
• Lacoma, A., et al., 2011. Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease. Clinica chimica acta; international journal of clinical chemistry, 412, 470–475.
   PubMed Web of Science ®Google Scholar
• Maisel, A., et al., 2010. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Journal of the American college of cardiology, 55, 2062–2076.
   PubMed Web of Science ®Google Scholar
• McCullough, P.A., et al., 2002. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation, 106, 416–422.
   PubMed Web of Science ®Google Scholar
• Moertl, D., et al., 2009. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. Journal of the American college of cardiology, 53, 1783–1790.
   PubMed Web of Science ®Google Scholar
• Morgenthaler, N.G., et al., 2004. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clinical chemistry, 50, 234–236.
   PubMed Web of Science ®Google Scholar
• Mueller, T., et al., 2005. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart, 91, 606–612.
   PubMed Web of Science ®Google Scholar
• Nagueh, S.F., et al., 2016. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography, 29, 277–314.
   PubMed Web of Science ®Google Scholar
• Nannaka, V., et al., 2015. Use of pro-BNP in the intensive care unit to predict outcomes in patients with acute exacerbation of COPD. Chest, 148, 675A.
   Web of Science ®Google Scholar
• Omland, T., 2008. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Critical care medicine, 36, S17–S27.
   PubMedGoogle Scholar
• Pervez, M.O., et al., 2017. Mid-regional pro-adrenomedullin in patients with acute dyspnea: data from the Akershus Cardiac Examination (ACE) 2 Study. Clinical biochemistry, 50, 394–400.
   PubMed Web of Science ®Google Scholar
• Ponikowski, P., et al., 2016. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European journal of heart failure, 18, 891–975.
   PubMed Web of Science ®Google Scholar
• Potter, L.R., 2011. Natriuretic peptide metabolism, clearance and degradation. The federation of European biochemical societies journal, 278, 1808–1817.
   PubMed Web of Science ®Google Scholar
• Rosjo, H., et al., 2015. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study. Clinical chemistry, 61, 1087–1097.
   PubMed Web of Science ®Google Scholar
• Shah, R.V., et al., 2012. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. European heart journal, 33, 2197–2205.
   PubMed Web of Science ®Google Scholar
• Skwarski, K., et al., 1993. Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease. Thorax, 48, 730–735.
   PubMed Web of Science ®Google Scholar
• Vesely, D.L., 2002. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression. International union of biochemistry and molecular biology, life, 53, 153–159.
   Google Scholar
• Vestbo, J., et al., 2013. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonarydisease: GOLD executive summary. American journal of respiratory and critical care medicine, 187, 347–365.
   PubMed Web of Science ®Google Scholar
• von Haehling, S., et al., 2007. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. Journal of the American college of cardiology, 50, 1973–1980.
   PubMed Web of Science ®Google Scholar
• Woods, R.L., 2004. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clinical and experimental pharmacology & physiology, 31, 791–794.
   PubMed Web of Science ®Google Scholar
• Youden, W.J., 1950. Index for rating diagnostic tests. Cancer, 3, 32–35.
   PubMed Web of Science ®Google Scholar